Invasive fungal disease (IFD), and particularly invasive aspergillosis, is a challenging cause of morbidity and mortality in patients undergoing alloSCT. 1, 2 Many studies, mainly from ...

The following represents disclosure information provided by authors of this manuscript. All relationships are considered compensated. Relationships are self-held unless noted. I = Immediate Family ...

"We know definitively that we can prevent almost all bleeding – decreasing bleeding frequency by > 90% as well as the severity of bleeding episodes – by continuing prophylaxis into adulthood or ...

Prophylactic G-CSF reduces the risk of FN and early deaths, including infection-related mortality, while increasing RDI and musculoskeletal pain. There are insufficient data to assess the impact of ...

With Gift Aid, your generous donation of £10 would be worth £12.50 at no extra cost to you. Yes, I want to Gift Aid any donations made to NAM now, in the future and in the past four years I am a UK ...

The authors concluded that for adult prophylaxis, riboflavin "is well tolerated, inexpensive and most controlled clinical trials have shown modest reductions in migraine headache frequency." ...

WOBURN, Mass.--(BUSINESS WIRE)--ROMEG Therapeutics, an innovative drug development company focused on alternative formulations to better meet clinical and patient needs, today announced that the U.S.

Please provide your email address to receive an email when new articles are posted on . Since the introduction of aggressive hemophilia prophylaxis in Sweden in the 1960s, there has been a dramatic ...

WHAT: Astellas Pharma US, Inc. ("Astellas"), a U.S. subsidiary of Tokyo-based Astellas Pharma Inc. (Tokyo: 4503), announced today that ASTAGRAF XL TM (tacrolimus extended-release capsules) for the ...

Cancer patients at patient advocacy events voice strong support for company's focus on patient quality of life and the highly neglected need for new therapies for cancer therapy-related diarrhea SAN ...